Clinical Trials Browser

INDUSTRY × Gastric Adenocarcinoma × Docetaxel × Clear all

NCT05705635 2023-01-31

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Gastric Adenocarcinoma